COMPANY

Healionics Corporation

Also known as Healionics · 6 sources

Profile checked Oct 10, 2026

Keywords: End Stage Renal Disease End Stage Kidney Disease (ESRD)

Funding and NIH signals

SEC Form D raise Raised $1.96M (Form D filed Dec 31, 2025). SEC Form D 0001413969-25-000002 (Dec 31, 2025)
Evidence (1 event)
- Dec 31, 2025 · SEC Form D 0001413969-25-000002
  Name of Issuer: Healionics CORP; CIK: 1413969; Address: Seattle, WA; Submission type: D; Filing date: 2025-12-31; Industry Group: Other; Date of First Sale: 2025-12-16; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 20000000; Total Amount Sold: 1964221; Federal exemptions: 06b

Job counts as of Oct 18, 2026. All funding and NIH signals

2026-10 Trial start Not phased (device or behavioral study): Multi-Site STARgraft (10401) Trial source ↗
Jan 29, 2026 Trial start Not phased (device or behavioral study): STARgraft (10401) Pilot source ↗
Sep 18, 2025 Grant Government grant — SBIR: $290,351 (annual award, as published), announced Sep 18, 2025. Agency: NIH/NHLBI. Source: government award database. source ↗
Nov 29, 2022 Trial start Not phased (device or behavioral study): Evaluation of STARgraft-3 for Hemodialysis source ↗
Feb 16, 2021 Trial start Not phased (device or behavioral study): Evaluation of STARgraft-2 for Hemodialysis Access source ↗
Apr 2, 2019 Trial start Not phased (device or behavioral study): Evaluation of STARgraft AV for Hemodialysis Access source ↗

2026-12 (ESTIMATED) · Not phased · STARgraft (10401) Pilot · NCT07555717
2027-06 (ESTIMATED) · Not phased · Multi-Site STARgraft (10401) Trial · NCT07557862

Estimated primary completion per ClinicalTrials.gov. Dates move.

Last 2 years.

Sep 18, 2025 Government grant — SBIR: $290,351 (annual award, as published), announced Sep 18, 2025. Agency: NIH/NHLBI. Source: government award database. source ↗

Record	Title	Phase	Status	Start	Primary completion
NCT07557862	Multi-Site STARgraft (10401) Trial	Not phased (device or behavioral study)	Not yet recruiting	2026-10	2027-06 (estimated)
NCT07555717	STARgraft (10401) Pilot	Not phased (device or behavioral study)	Recruiting	Jan 29, 2026	2026-12 (estimated)
NCT05729620	Evaluation of STARgraft-3 for Hemodialysis	Not phased (device or behavioral study)	Active, not recruiting	Nov 29, 2022	Feb 2, 2024 (actual)
NCT03916731	Evaluation of STARgraft AV for Hemodialysis Access	Not phased (device or behavioral study)	Completed	Apr 2, 2019	Oct 17, 2020 (actual)
NCT04783779	Evaluation of STARgraft-2 for Hemodialysis Access	Not phased (device or behavioral study)	Completed	Feb 16, 2021	Jun 1, 2022 (actual)